Eluracat

Authorised

This medicine is authorised for use in the European Union

capromorelin tartrate

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Product details

• Name of medicine:
  Eluracat
• Active substance:
  capromorelin tartrate
• International non-proprietary name (INN) or common name:
  capromorelin tartrate

Pharmacotherapeutic group

Anterior pituitary lobe hormones and analogues

Authorisation details

• EMA product number:
  EMEA/V/C/005948

Assessment history

Initial marketing authorisation documents

CVMP summary of positive opinion for Eluracat

AdoptedReference Number: EMA/CVMP/194243/2023